Percutaneous coronary intervention combined with treat-repair-treat strategy in a patient with pulmonary arterial hypertension associated with atrial septal defect and left main coronary compression syndrome
- PMID: 39712237
- PMCID: PMC11658559
- DOI: 10.1016/j.ijcchd.2023.100458
Percutaneous coronary intervention combined with treat-repair-treat strategy in a patient with pulmonary arterial hypertension associated with atrial septal defect and left main coronary compression syndrome
Erratum in
-
Erratum regarding missing Disclosure statement in previously published articles.Int J Cardiol Congenit Heart Dis. 2024 Feb 20;15:100498. doi: 10.1016/j.ijcchd.2024.100498. eCollection 2024 Mar. Int J Cardiol Congenit Heart Dis. 2024. PMID: 39713500 Free PMC article.
Abstract
Compression of left main coronary artery is a severe complication in PAH and the treatment strategy is tricky and should be individualized. We presented a patient with large atrial septal defect (ASD) and non-Eisenmenger pulmonary arterial hypertension (PAH). Right heart catheterization (RHC) showed the defect was non-correctable due to a pulmonary vascular resistance (PVR) of 9.49 Wood Units. EKG suggested myocardial ischemia and coronary angiography and coronary CTA confirmed proximal left main coronary artery was compressed by extremely dilated pulmonary arterial trunk, which is named left main coronary compression syndrome (LMCS). Percutaneous coronary intervention (PCI) using drug-eluting stent was performed and combined PAH-specific medications was prescribed simultaneously. At 6-month following the PCI procedure, PVR had decreased to 3.43 Wood Units, and percutaneous ASD closure procedure was performed. A 6-month follow-up the patient was asymptomatic and had significantly improved pulmonary hemodynamics. LMCS is rare among patients with ASD-PAH. PCI combined with PAH-specific medications allowed the closure of ASD, resulting in clinical improvement.
Keywords: Atrial septal defect; Case report; Left main coronary compression syndrome; Pulmonary arterial hypertension.
© 2023 Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Demerouti E.A., Manginas A.N., Athanassopoulos G.D., Karatasakis G.T. Complications leading to sudden cardiac death in pulmonary arterial hypertension. Respir Care. 2013;58(7):1246–1254. - PubMed
-
- Kajita L.J., Martinez E.E., Ambrose J.A., Lemos P.A., Esteves A., Nogueira da Gama M., Jatene A.D., Ramires J.A. Extrinsic compression of the left main coronary artery by a dilated pulmonary artery: clinical, angiographic, and hemodynamic determinants. Cathet Cardiovasc Interv. 2001;52(1):49–54. - PubMed
-
- Akbal O.Y., Kaymaz C., Tanboga I.H., Hakgor A., Yilmaz F., Turkday S., Dogan C., Tanyeri S., Demir D., Bayram Z., Cicek M.B., Acar R.D., Ozdemir N. Extrinsic compression of left main coronary artery by aneurysmal pulmonary artery in severe pulmonary hypertension: its correlates, clinical impact, and management strategies. Eur Heart J Cardiovasc Imaging. 2018;19(11):1302–1308. - PubMed
-
- Galiè N., Saia F., Palazzini M., Manes A., Russo V., Bacchi Reggiani M.L., Dall'Ara G., Monti E., Dardi F., Albini A., Rinaldi A., Gotti E., Taglieri N., Marrozzini C., Lovato L., Zompatori M., Marzocchi A. Left main coronary artery compression in patients with pulmonary arterial hypertension and angina. J Am Coll Cardiol. 2017;69(23):2808–2817. - PubMed
-
- Humbert Marc, Kovacs Gabor, Hoeper Marius M., Badagliacca Roberto, Berger Rolf M.F., Brida Margarita, Carlsen Jørn, Coats Andrew J.S., Escribano-Subias Pilar, Ferrari Pisana, Ferreira Diogenes S., Ardeschir Ghofrani Hossein, George Giannakoulas, Kiely David G., Mayer Eckhard, Meszaros Gergely, Nagavci Blin, Olsson Karen M., Pepke-Zaba Joanna, Quint Jennifer K., Rådegran Göran, Simonneau Gerald, Olivier Sitbon, Tonia Thomy, Toshner Mark, Luc Vachiery Jean, Vonk Noordegraaf Anton, Delcroix Marion, Rosenkranz Stephan, ESC/ERS Scientific Document Group . European Heart Journal; 2022. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG) p. ehac237.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
